Image of an ambulance on the road depicting the NHS mobile liver cancer testing trucks

NHS mobile testing finds thousands of new patients at risk of liver cancer

The NHS’s innovative mobile testing programme has identified thousands of more people in danger of getting liver cancer after visiting England’s highest risk communities.

Between June 2022 and September 2023, the roaming liver trucks have delivered more than 26,500 fibroscans and subsequently found 2,204 patients with cirrhosis or advanced fibrosis – a leading cause of liver cancer.

Across 18 areas of England, the 12 vehicles have scanned people everywhere from GP practices to diabetes and sexual health clinics.

In a bid to catch the cancer as early as possible, adults with high alcohol consumption, non-alcoholic liver disease, or a current/previous diagnosis of viral hepatitis are being offered the checks, as these all increase the risk of developing liver cancer.

Approximately 6,200 people are diagnosed with liver cancer each year and only a third are caught at an early stage. When detected sooner, patients have a 45% chance of survival for five years or more – that probability goes down to 5% if found at stage four.

NHS England’s national clinical director for cancer, Professor Peter Johnson, said: “We are seeing liver cancers increasing year on year, but finding them early gives the best chance of successful treatment, which is why we have set up this initiative that is having such a positive impact and making it easier for people who are at a higher risk of liver cancer or other organ damage to get life-saving checks.”

He continued: “Bringing liver scans into the heart of communities has already helped us find thousands of people with liver damage that needs further monitoring, investigation, or treatment; and in the future, we expect to help tens of thousands more patients receive a diagnosis sooner.

Those who are considered to be at a high-risk of liver cancer are provided with information about their condition and referred to a GP if necessary.

Patients can also be put under a six-month liver surveillance scheme, where a dedicated support worker will offer guidance and share advice from those who have experienced liver disease themselves.

Prof Johnson added: “Lives are saved when cancers are caught early and when more people are referred for tests, which is why the NHS has put so much effort into early diagnosis in recent years, as well as increasing access to testing.”

Image credit: iStock

NHE March/April 2024

NHE March/April 2024

A window into the past, present and future of healthcare leadership.

- Steve Gulati, University of Birmingham 

More articles...

View all
Online Conference

Presenting

2024 Online Conferences

In partnership with our community of health sector leaders responsible for delivering the UK's health strategy across the NHS and the wider health sector, we’ve devised a collaborative calendar of conferences and events for industry leaders to listen, learn and collaborate through engaging and immersive conversation. 

All our conferences are CPD accredited, which means you can gain points to advance your career by attending our online conferences. Also, the contents are available on demand so you can re-watch at your convenience.

National Health Executive Podcast

Ep 42. Leadership in the NHS

In episode 42 of the National Health Executive podcast we were joined by Steve Gulati who is an associate professor at the University of Birmingham as well as director of healthcare leadership at the university’s Health Services Management Centre.